Review: could Beyaz cause Alopecia (Hair loss)?
Summary: Alopecia is found among people who take Beyaz, especially for people who are female, 20-29 old, have been taking the drug for 5 - 10 years, also take medication Iron supplement, and have Birth control.
We study 820 people who have side effects while taking Beyaz from FDA and social media. Among them, 6 have Alopecia. Find out below who they are, when they have Alopecia and more.
You are not alone: join a mobile support group for people who take Beyaz and have Alopecia >>>
Beyaz has active ingredients of drospirenone; ethinyl estradiol; levomefolate calcium. It is often used in birth control. (latest outcomes from 853 Beyaz users)
Alopecia (absence of hair from areas of the body) has been reported by people with high blood pressure, rheumatoid arthritis, high blood cholesterol, multiple sclerosis, depression. (latest reports from 42,705 Alopecia patients)
On Mar, 2, 2015: 820 people reported to have side effects when taking Beyaz. Among them, 6 people (0.73%) have Alopecia.
Time on Beyaz when people have Alopecia * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
Age of people who have Alopecia when taking Beyaz * :
Severity of Alopecia when taking Beyaz ** :
|least||moderate||severe||most severe |
How people recovered from Alopecia ** :
|while on the drug||after off the drug||not yet |
Top conditions involved for these people * :
- Contraception (2 people, 33.33%)
- Acne (1 people, 16.67%)
- Depression (1 people, 16.67%)
- Acne fulminans (1 people, 16.67%)
Top co-used drugs for these people * :
- Iron supplement (1 people, 16.67%)
- Vitamin d (1 people, 16.67%)
- Accutane (1 people, 16.67%)
- Celexa (1 people, 16.67%)
- Fish oil (1 people, 16.67%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Get connected: join our support group of beyaz and alopecia on
Do you have Alopecia while taking Beyaz?
You are not alone! Join a mobile support group on :
- support group for people who take Beyaz and have Alopecia
- support group for people who take Beyaz
- support group for people who have Alopecia
Drugs in real world that are associated with:
Could your condition cause:
Recent Beyaz related drug comparison:
- Comparions of Ortho Tri-cyclen Lo, Beyaz for a 28-year old woman who has Birth Control
- Comparions of Beyaz, Prozac for a 30-year old woman who has Premenstrual Dysphoric Disorder
- Comparions of Ortho Evra, Beyaz, Ortho Tri-cyclen Lo, Lo Loestrin Fe for a 32-year old woman who has Test
- Comparions of Beyaz (Bayer Hlthcare) - 3MG,N/A;0.02MG,N/A;0.451MG,0.451MG, Bystolic (Forest Labs) - EQ 2.5MG BASE for a 23-year old woman who has Postural Orthostatic Tachycardia Syndrome
- Comparions of Safyral, Seasonique for a 29-year old woman who has Birth Control
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.